Effects on serum lipid profiles of continuous 17β-estradiol, intermittent norgestimate regimens versus continuous combined 17β-estradiol/ norethisterone acetate hormone replacement therapy

This publication has 36 references indexed in Scilit:

• The effect of a cyclophasic estrogen/progestogen regimen on blood lipid levels in postmenopausal women
  Obstetrics & Gynecology, 1999
• Triglyceride as a risk factor for coronary artery disease
  The American Journal of Cardiology, 1998
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction
  Published by Elsevier ,1998
• Lipoprotein Lp(a) excess and coronary heart disease
  Archives of internal medicine (1960), 1997
• Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial
  JAMA, 1996
• Sex hormones, lipoproteins, and vascular reactivity
  Current Opinion in Lipidology, 1995
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
  JAMA, 1993
• Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.
  BMJ, 1989
• Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylene glycol
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1985